The biotec start up behind the oxford astrazinacavacine, filed for an ipo yesterday. It could price its offering as early as this month. Vaxite is the british company that owns the bio technology vaccine,. and it plans to list, not in london, but in new york. Hannah cushler is the f ts global farma correspondent.